Controversies in cardiothoracic surgery: Is it ethical to advertise surgical results to increase referrals?  by McKneally, Martin F.
Controversies in cardiothoracic surgery: Is it ethical to
advertise surgical results to increase referrals?
Martin F. McKneally, MD, PhD
Should our profession accept medical advertising as ethically appropriate? This
issue was vigorously debated at the May 2001 Annual Meeting of The American
Association for Thoracic Surgery (AATS) in San Diego.
Pro: Delos Cosgrove, from The Cleveland Clinic, gave a historical overview of
the evolution of the relationship between advertising and medicine in the United
States. Medical advertising was viewed as unethical in the United States until 1975,
when the Federal Trade Commission ruled that the American Medical Association’s
ban on advertising was a restraint of trade, violating a fundamental principle of
American capitalism. After a 7-year battle, the Supreme Court narrowly upheld the
decision of the lower courts that the ban violated federal law. The AMA acquiesced,
lifting all restrictions except those that protect patients from deceptive advertising.
Cosgrove effectively proved that the law in the United States was on his side.
Turning to policy, he cited statements of the American Hospital Association:
“Healthcare advertising should be truthful, fair, accurate, complete and sensitive to
the health care needs of the public. False or misleading statements, or statements
that might lead the uninformed to draw false conclusions . . . are unacceptable and
unethical”; the American College of Physicians: “Advertising by physicians is
unethical when it contains statements that are unsubstantiated, false, deceptive, or
misleading, including misleading by omitting necessary information”; and the
American College of Surgeons: “Communications to the public must not convey
false, untrue, deceptive, or misleading information through statements, testimonials,
photographs, graphics, or other means.” Cosgrove concluded that our medical
organizations prohibit deception but clearly endorse the right to advertise.
He presented empiric evidence of approval within the profession. Expenditures
for medical advertising are increasing at a rate of 50% per year. By very conser-
vative estimates, hospitals were responsible for spending $167 million on advertis-
ing in 2000 and physicians spent $27 million. More generous estimates of expend-
itures for medical advertising by hospitals have been as high as $1.3 billion. Three
surveys conducted in 1979, 1983, and 1986 indicate that consumers want informa-
tion about health care and have a favorable attitude toward medical advertising.
Cosgrove displayed The Cleveland Clinic Web site page on surgical outcomes to
show how advertising can provide patients with the clear, quantifiable information
they require.
Con: Before presenting the case against advertising surgical results to increase
referrals, Craig Miller, of Stanford University, drew uproarious laughter from the
audience by handing moderator Tirone David his gun belt, throwing knife, and
grenade. He commended The Cleveland Clinic for taking the high road in its
approach to advertising, providing valuable information and research results to
patients and physicians, and he acknowledged Cosgrove’s point that medical ad-
vertising is legal. But laws are not immutable and are not always consistent with
high ethical standards. He pointed out that the 1982 Supreme Court decision to
uphold the lower court was as close as it could have been, with the vote split 4 to
4.
To illustrate how unethical advertising can mislead, Miller presented Web sites
from several other medical institutions that display outdated and pirated statistics or
make claims that appeal to the emotions and exploit the ignorance of vulnerable
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patients. Such advertising is designed to please shareholders
and attract patients by persuasion rather than information.
Miller described the transformation of medicine from a
profession to a business, tracing the change to 1965, when
Medicare was introduced in the United States. In Miller’s
view this change triggered an erosion of the professionalism
that emphasized serving the patient, including voluntary
care of the poor, in favor of a commercial business mental-
ity that refers to patients as clients and consumers. He
quoted the South African physician-ethicist Solomon Bena-
tar, who has said that overemphasis on the entrepreneurial
business model has led to the loss of medicine’s soul.
Rebuttals: Cosgrove referred to The Cleveland Clinic’s
policy of publishing not only its successes, but also its
complications and problems, informing patients and refer-
ring physicians through medical publications, a form of
doctor to doctor advertising of surgical results that benefits
patients when done honestly and well.
Miller reminded the audience that The Cleveland Clinic
is not representative of most medical advertisers. Examples
of deceptive advertising abound, such as the commercials
recently banned by the Food and Drug Administration for
depicting patients with arthritis receiving anti-inflammatory
drugs and patients with acquired immunodeficiency syn-
drome receiving antiviral drugs as robust and healthy ath-
letes. Arguing for individual and professional accountability
rather than regulation, he invoked the spirit of Leo Eloesser,
20th president of the AATS: “In the last 5000 years, at-
tempts to assure integrity by laws and regulations and paper
have failed.” Miller concluded his call to professional rather
than commercial values by quoting former president of the
AATS and chairman of the board of The Cleveland Clinic,
Floyd Loop, who warned that “the brokers, the money
changers, the payers are in charge, not the provider or
receiver of health care . . . . Commercialism in medicine is
relentless and, if it persists, will erode trust between physi-
cian and patient, and economics will drive ethics even more
than it does today.”
Moderator Tirone David invited comments from the in-
ternational members of the audience to broaden the scope of
discussion. Alain Carpentier remarked that in France both
wearing a gun belt and advertising medical results are
forbidden. Advertising, unlike information, is inevitably
biased. To truly benefit patients, Carpentier suggested, in-
formation must be complete and should be validated by an
independent organization such as the AATS. Robert Gins-
berg of Toronto commented that medical information is
readily available to patients by other means and that the
billion dollars spent on advertising in the United States
could be better spent on providing health care.
Comment: Our Editor, Andy Wechsler, asked me how
surgeons should think about advertising in relation to in-
formed consent. The legal doctrine of informed consent is
based on the ethical principle of respect for autonomy—the
right to determine what will or will not be done to one’s
own body. Informative medical advertising is generally
regarded as ethically defensible because it respects the
autonomy of consumers of health care information. While
informing them about the treatment, physician, or institu-
tion, such advertising respectfully leaves the potential pa-
tient free to accept or reject the claims without being fright-
ened or manipulated by innuendo. Persuasive advertising is
morally questionable or wrong when applied to medicine
because it overrides autonomy by manipulation of subcon-
scious desires, associations, and vulnerabilities.1,2
Because consent is not an event, but a process, informa-
tive advertising that contains incomplete information may
create a problem when the patients make the initial decision
to accept treatment. This commitment often happens early,
long before the formal discussion that we associate with the
signing of a consent form. That later event may be the first
time that the risks and alternatives are discussed. Patients
may then be so far downstream from their initial decision
that they feel too committed emotionally, physically, and
socially to reverse their position. For this reason, I think that
informative advertising that does not include disclosure of
the risks and the alternatives, as well as the benefits, can be
morally problematic in the consent process. Cosgrove em-
phasized that complications and problems are disclosed in
the medical literature, a form of advertising to the profes-
sion, but not in advertising that is directed to the lay public.
Informative advertising to the public would be more ethi-
cally acceptable, in my view, if the risks and alternatives
were also described.
Andy then asked how an ethicist would resolve the issue
that Toby Cosgrove and Craig Miller debated. In short, is
there a correct answer, or does ethical analysis always lead
to a regression of ambiguities: “on the one hand . . . , on the
other . . . , on a third view . . . ?” My answer is that an issue,
by definition, is a matter in dispute. The lens of theoretical
ethical analysis is a prism that allows an ethicist to diffract
out, like the color elements of light, the essential values,
shades of meaning, and circumstances that help us to un-
derstand and adjudicate the issue. After separating out these
elements, an ethicist would describe multiple justifiable
positions in an abstract analysis. Like electricity, which can
be used for torture or illumination, medical advertising is
intrinsically value neutral; its application determines its
ethical standing. However, in analyzing a concrete, partic-
ular case, a clear and unambiguous “correct answer” can
and would be provided by a legitimate ethical authority.
When the question is whether a given advertisement meets
the ethical standards of the profession, the Standards and
Ethics Committee of the Society of Thoracic Surgeons can
speak with authority. In one of the worst examples of
advertising reviewed by the Committee, profound emo-
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tional manipulation of vulnerable patients was combined
with deceptive statistics. “You only have one heart; why
take a chance? . . . 0.0% mortality . . . .” The Committee
unambiguously judged this advertisement misleading and
unethical, as would any ethicist.
Our debaters have clearly established ethics discourse as
part of the AATS meeting program with great style; their
reflective analysis, scholarship, and humor made the debate
a highlight of the meeting. A visit to http://aats.e-studiolive.
net/main.html on the Web will allow you to share the fun
and excitement of the experience, including an interesting
view of the protagonists in ceremonial headgear.
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